CRWV (NASDAQ: CRWV) insiders plan 50,000-share Rule 144 stock sale

Rhea-AI Filing Summary

CRWV insiders have filed a Rule 144 notice covering the planned sale of 50,000 shares of common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $5,443,000, and will trade on NASDAQ.

The securities were originally acquired as founder shares on November 13, 2017. The filing also lists multiple sales of common stock during the past three months by Michael Intrator, Omnadora Capital LLC, and a non-affiliate donee under Rule 10b5-1 trading arrangements, reflecting ongoing programmed selling activity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	5443000.00	386401201	01/28/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			50000	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/14/2026	32455	2901243.32
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/14/2026	50000	4469640.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/06/2026	61386	4674746.47
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	32456	2334725.61
MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	78971	5731033.94
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	50000	3596755.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/17/2025	32455	2124981.39
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/17/2025	50000	3273735.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/03/2025	32455	2495279.96
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/03/2025	50000	3844215.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/19/2025	32455	2424654.63
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/19/2025	50000	3735410.00
Non-Affiliate Donee 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/14/2025	75000	5946097.50
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/05/2025	32455	3698951.52
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/05/2025	50000	5698585.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CRWV Form 144 filing disclose?

The filing discloses a planned sale of 50,000 CRWV common shares under Rule 144. These shares are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, indicating an intention by insiders to continue monetizing part of their holdings.

How many CRWV shares are covered by this planned Rule 144 sale?

The notice covers 50,000 shares of CRWV common stock. At the time of the filing, there were 386,401,201 common shares outstanding, providing context for the size of this planned transaction relative to the company’s total equity base.

What is the aggregate market value of the CRWV shares to be sold?

The 50,000 CRWV shares have an aggregate market value of $5,443,000. This reflects the approximate value of the planned sale through Morgan Stanley Smith Barney LLC, based on prevailing market prices at the time the notice was prepared.

When were the CRWV shares being sold originally acquired?

The shares described in the Form 144 were acquired on November 13, 2017 as founder shares from the issuer. This long holding period aligns with Rule 144 requirements for resales of restricted or control securities by affiliates.

What recent CRWV stock sales are listed in the past three months section?

The filing lists multiple recent sales of CRWV common stock by Michael Intrator, Omnadora Capital LLC, and a non-affiliate donee. Many of these were executed under Rule 10b5-1 trading plans, with block trades on various dates in November 2025 through January 2026.

Through which broker and exchange will the CRWV shares be sold?

The planned Rule 144 sale will use Morgan Stanley Smith Barney LLC Executive Financial Services as broker. The shares are listed for sale on the NASDAQ exchange, consistent with the issuer’s trading venue for its common stock.